MedImmune and Incyte announce collaboration on immuno-oncology combination clinical trial
AstraZeneca announced that MedImmune, its global biologics research and development…
14 May 2014 | By AstraZeneca
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a clinical study collaboration with biopharmaceutical company Incyte Corporation...